Jan-Niklas Eckardt
16PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Feb 20, 2026
Artificial intelligence-generated synthetic data for cancer research and clinical trials.Jan-Niklas Eckardt, Waldemar Hahn, Arsela Prelaj
|Oct 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner
|Jul 28, 2025
Promises and challenges of artificial intelligence in haematological diagnostics.Jan-Niklas Eckardt, Jan Moritz Middeke
|May 08, 2025
Age-stratified machine learning identifies divergent prognostic significance of molecular alterations in AML.Jan-Niklas Eckardt, Waldemar Hahn, Rhonda E Ries
|Mar 05, 2025
The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML.Sebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig
|Mar 21, 2024
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence.Jan-Niklas Eckardt, Waldemar Hahn, Christoph Röllig
Pageof 3
Frequent Collaborators
10 joint publications
Sebastian Stasik
10 joint publications
Stefan W Krause
8 joint publications
Christoph Röllig
8 joint publications
Christian Thiede
7 joint publications
Christoph Schliemann
7 joint publications
Claudia D Baldus
7 joint publications
Martin Bornhäuser
7 joint publications
Johannes Schetelig
5 joint publications
Andreas Burchert
5 joint publications
Jan Moritz Middeke
